Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation

Abstract

Ovarian cancer (OC) is the most lethal gynecologic malignancy, and melatonin has shown various antitumor properties. Herein, we investigated the influence of melatonin therapy on energy metabolism and mitochondrial integrity in SKOV-3 cells and tested whether its effects depended on MT1 receptor activation. SKOV-3 cells were exposed to different melatonin concentrations, and experimental groups were divided as to the presence of MT1 receptors (melatonin groups) or receptor absence by RNAi silencing (siRNA MT1+melatonin). Intracellular melatonin levels increased after treatment with melatonin independent of the MT1. The mitochondrial membrane potential of SKOV-3 cells decreased in the group treated with the highest melatonin concentration. Melatonin reduced cellular glucose consumption, while MT1 knockdown increased its consumption. Interconversion of lactate to pyruvate increased after treatment with melatonin and was remarkable in siRNA MT1 groups. Moreover, lactate dehydrogenase activity decreased with melatonin and increased after MT1 silencing at all concentrations. The UCSC XenaBrowser tool showed a positive correlation between the human ASMTL gene and the ATP synthase genes, succinate dehydrogenase gene (SDHD), and pyruvate dehydrogenase genes (PDHA and PDHB). We conclude that melatonin changes the glycolytic phenotype and mitochondrial integrity of SKOV-3 cells independent of the MT1 receptor, thus decreasing the survival advantage of OC cells.

Why do anti-amyloid beta antibodies not work? Time to reconceptualize dementia pathophysiology by incorporating astrocyte melatonergic pathway desynchronization from amyloid-beta production

“…Given that melatonin treatment in human dementia and animal models shows benefits, 7 it is surprising that its local production in the central nervous system has not been clinically investigated. Notably, exogenous melatonin induces the mitochondrial melatonergic pathway, partly via Bmal1, SIRT1, and SIRT3 induction, 8 thereby disinhibiting the pyruvate dehydrogenase complex and the conversion of pyruvate to acetyl-CoA, which is required as an AANAT co-substrate to initiate the melatonergic pathway ( Figure 1 ).…”

Type I Diabetes Pathoetiology and Pathophysiology: Roles of the Gut Microbiome, Pancreatic Cellular Interactions, and the ‘Bystander’ Activation of Memory CD8+ T Cells

“…The tryptophan–melatonin pathway is evident in cells across body organs and tissues, with relevance to a host of diverse medical conditions, including depression [ 36 ], amyotrophic lateral sclerosis [ 7 ], cancers [ 113 ] and dementia [ 97 ]; see Figure 1 . Most tryptophan is derived from dietary sources, although the shikimate pathway in the human gut microbiome is a relevant provider of aromatic amino acids, including tryptophan, as well as tyrosine and phenylalanine [ 7 ].…”

Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue

“…These changes do, however, coincide with the reduction in circulating nocturnal melatonin levels as well as the presumed loss of melatonin production in the mitochondria of the ovarian cells [ 72 , 124 ] ( Figure 2 ). This is relevant since the mitochondria play a central role in oocyte aging and the reduction in melatonin in this organelle significantly influences their function; the mitochondria of pathological cells have melatonin concentrations approximately only half those of healthy cells [ 125 , 126 ]. Such greatly depressed levels of this important mitochondrial reducing agent likely allow for the more rapid accumulation of oxidatively damaged molecules.…”